BioCentury
ARTICLE | Clinical News

IntraBiotics starts Ramoplanin Phase III

June 29, 2000 7:00 AM UTC

IBPI began U.S. Phase III testing of its oral Ramoplanin inhibitor of gram-positive bacterial cell wall synthesis to reduce the incidence of bloodstream infections due to vancomycin-resistant enteroco...